Medpace Holdings ROE - Return on Equity 2014-2024 | MEDP

Medpace Holdings return on equity for the quarter ending September 30, 2024 was 50.76.

  • Medpace Holdings average return on equity for 2023 was 70.25, a 79.76% decline from 2022.
  • Medpace Holdings average return on equity for 2022 was 39.08, a 89.34% increase from 2021.
  • Medpace Holdings average return on equity for 2021 was 20.64, a 24.71% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

Medpace Holdings ROE - Return on Equity 2014-2024 | MEDP

  • Medpace Holdings average return on equity for 2023 was 70.25, a 79.76% decline from 2022.
  • Medpace Holdings average return on equity for 2022 was 39.08, a 89.34% increase from 2021.
  • Medpace Holdings average return on equity for 2021 was 20.64, a 24.71% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.